A large international study shows that metabolomic signatures in maternal blood, especially later in pregnancy, reveal hidden metabolic risk and predict gestational diabetes and preeclampsia more ...

An innovative evidence-based laboratory medicine (EBLM) test to help doctors in the basic assessment of colorectal cancer. Trend analysis of risk factors for early-onset primary colorectal cancer: A ...

Fecal metabolomic profiling in Crohn’s disease reveals distinct metabolite patterns linked to disease activity, location, and ...

Tyrosine kinase inhibitors (TKIs) have transformed cancer therapy by targeting specific enzymes crucial for tumour growth and survival. Central to their clinical development is the robust assessment ...

Asthma metabolomics uncovered biologically distinct disease subtypes in clinically stable patients. Learn more about the ...

Serendipity is to thank for several ground-breaking discoveries and treatments, such as Alexander Fleming’s accidental discovery of penicillin. 1 However, most drug breakthroughs stem from systematic ...

Serum metabolic signatures at MS onset are associated with disease activity and progression but offer modest long-term prognostic value.

Higher levels of non-estrogen hormones, along with stress and elevated BMI, are linked to earlier breast development in girls ...

Metabolite data and AI combine to redefine how we measure aging and predict health spans. Study: Metabolomic age (MileAge) predicts health and life span: A comparison of multiple machine learning ...